DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
The FY26 ALS Research Program Therapeutic Idea Award funds new, high-risk, high-reward ideas for drug or therapy discovery in amyotrophic lateral sclerosis (ALS). Projects should be hypothesis-driven and can rely on a strong approach even without extensive preliminary data, while aiming to produce results that enable future therapeutic directions.
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
National Institutes of Health
-
Biomedical Research Projects
Motor Neurone Disease Association
-
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of Health
-
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
National Center for Advancing Translational Sciences
-
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers